Directorate Change

    Death of non-executive director of SR Pharma plc                

London, 23 July 2003 - SR Pharma plc regretfully announces the death of
Professor Tim Chard who was a non-executive director of the company.

Chairman Eric Boyle said: "It is with deep sadness that we announce the death
of Tim Chard on Sunday 20th July. Our thoughts and sincere condolences go out
to his family and friends at this time.

Tim became a director of the company in February 1997 and since then
demonstrated a real commitment to the development of the business. His presence
will be greatly missed by us all."

About SR Pharma
SR Pharma plc (www.srpharma.com) was founded in 1992 and develops novel
medicines based on an improved understanding of the role played by the immune
system in combating disease. The company's proprietary M. vaccae-based
technology is the source of a number of product developments. SR Pharma is
currently evaluating SRP299 and AVAC(TM) for the treatment of asthma and atopic
dermatitis. The company is also investigating SRL172 as a vaccine adjuvant in
cancer and infectious diseases. These products enhance the immune responses
needed to combat cancer and infection, while regulating those that mediate
allergies.

For further information please contact:

Steeve Lamontagne, SR Pharma plc

Tel: [phone]

Email: [e-mail]



END